Moderna (MRNA) and Alnylam (ALNY) resolve a patent dispute related to the technology used in former's COVID-19 vaccine. Read ...

After swiftly developing its COVID-19 vaccine in 2020 and launching it late that year, Moderna soon found itself facing ...

Moderna announced today that the first mRNA vaccines fully manufactured in Canada are being shipped to provinces and ...

While mRNA changed the game in vaccines, leveraging the technology to develop treatments has been trickier to navigate.

Moderna’s new Laval-based facility supports onshore vaccine production, bolsters health and economic resilience, and ...

Moderna has settled related lawsuits that accused it of misusing Alnylam Pharmaceuticals' patented technology in its COVID-19 ...

Preliminary analysis showed the 2025-2026 formula of Spikevax generated greater than an 8-fold increase in ...

What Happened? Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 4% in the morning session after the company announced positive preliminary data for its updated 2025-2026 COVID-19 vaccine, ...

RFK Jr. recently made major cuts to mRNA vaccine development research, questioning their safety. Should you still get the mRNA COVID vaccine?

NEW YORK -- When the final Phase 3 data came out last November showing the mRNA vaccines made by Pfizer/BioNTech and Moderna were more than 90% effective, Dr. Anthony Fauci had no words. He texted ...

Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 4.8% in the afternoon session after competitors Pfizer and ...

In the latest trading session, Moderna (MRNA) closed at $25.51, marking a +2.03% move from the previous day. This change outpaced the S&P 500's 0.48% gain on the day. On the other hand, the Dow ...